HCA Healthcare, Inc. - Common Stock (HCA)

Historical Holders from Q1 2014 to Q3 2025

Symbol
HCA on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
248M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
136M
Holdings value
$58.1B
% of all portfolios
0.046%
Grand Portfolio weight change
-0.007%
Number of holders
1267
Number of buys
561
Number of sells
-570
Average Value change %
-0.01%
Average buys %
+0.005%
Average sells %
-0.013%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of HCA Healthcare, Inc. - Common Stock (HCA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 4.9% $4.06B 12.1M BlackRock, Inc. 31 Mar 2025

Institutional Holders of HCA Healthcare, Inc. - Common Stock (HCA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 136M $58.1B -$4.12B $426.20 1,267
2025 Q2 147M $56.1B -$1.85B $383.10 1,239
2025 Q1 152M $52.6B -$2.01B $345.55 1,214
2024 Q4 158M $47.6B -$8.74M $300.15 1,169
2024 Q3 158M $64B -$2.6B $406.43 1,192
2024 Q2 164M $52.6B -$183M $321.28 1,151
2024 Q1 164M $54.6B -$1.09B $333.53 1,116
2023 Q4 168M $45.5B -$285M $270.68 1,047
2023 Q3 169M $41.6B -$1.19B $245.98 989
2023 Q2 173M $52.6B -$667M $303.48 1,006
2023 Q1 175M $46.2B -$839M $263.68 958
2022 Q4 180M $43.1B -$1.14B $239.96 949
2022 Q3 185M $34B -$753M $183.79 849
2022 Q2 188M $31.7B -$1.59B $168.06 854
2022 Q1 198M $49.8B -$1.67B $250.62 950
2021 Q4 205M $52.6B -$1.56B $256.92 931
2021 Q3 211M $51.2B -$2.7B $242.72 870
2021 Q2 221M $45.8B -$1.47B $206.74 805
2021 Q1 231M $43.6B -$1.18B $188.34 777
2020 Q4 237M $39B +$224M $164.46 765
2020 Q3 237M $29.5B +$374M $124.68 709
2020 Q2 234M $22.7B +$114M $97.06 676
2020 Q1 234M $21B -$501M $89.85 691
2019 Q4 238M $35.1B +$69.1M $147.81 707
2019 Q3 237M $28.6B -$391M $120.42 668
2019 Q2 241M $32.5B +$200M $135.17 666
2019 Q1 243M $31.6B -$72.6M $130.38 692
2018 Q4 243M $30.2B -$152M $124.45 691
2018 Q3 244M $33.9B -$405M $139.12 649
2018 Q2 247M $25.3B -$454M $102.60 640
2018 Q1 251M $24.3B -$605M $97.00 607
2017 Q4 258M $22.6B -$1.13B $87.84 557
2017 Q3 270M $21.5B +$433K $79.59 523
2017 Q2 270M $23.5B -$283M $87.20 565
2017 Q1 274M $24.4B +$1.92B $88.99 569
2016 Q4 274M $20.3B +$125M $74.02 565
2016 Q3 272M $20.5B -$513M $75.63 577
2016 Q2 278M $21.4B -$926M $77.01 606
2016 Q1 290M $22.6B -$262M $78.05 581
2015 Q4 296M $20B -$1.06B $67.63 575
2015 Q3 310M $23.9B -$349M $77.36 630
2015 Q2 313M $28.4B -$596M $90.72 651
2015 Q1 321M $24.2B +$212M $75.23 591
2014 Q4 318M $23.4B -$834M $73.39 540
2014 Q3 329M $23.2B +$543M $70.52 499
2014 Q2 324M $18.2B -$766M $56.38 437
2014 Q1 338M $17.7B +$311M $52.50 399